What Has Actually Changed At Nutrien (NTR)?

If you picked up the Nutrien story through its record potash volumes and upbeat analyst coverage, the last year probably felt rewarding. Holding Nutrien over the past year would have returned 22.7%, including dividends. If you were making that call back on 2 October 2025, you had only the bull and bear arguments on automation, regulation and long term fertilizer demand on record. Which side of that split did you need to believe to justify buying before the later earnings beats and portfolio moves arrived?

The easy part of this move is behind Nutrien. Zero in on 6 high quality undervalued stocks for companies trading below our estimates.

The Two Nutrien Stories Investors Had To Weigh

The shares cost CA$83.39 at the start, and Nutrien sat between two very different stories that both sounded reasonable.

On the bullish side, the optimistic Narrative suggested a Fair Value of CA$96.77, a price implied by expectations that heavy potash automation and production flexibility would support stronger profitability. Supporters focused on automation already covering a large share of ore mining and the idea that this could underpin industry leading margins.

The cautious Narrative pointed to a Fair Value of CA$62.24, again an implied price built from its own set of assumptions. That view focused on stricter environmental rules and rising carbon costs, which could lift Nutrien’s compliance and input expenses and potentially squeeze future margins.

What The Results Changed For The Nutrien Thesis

Nutrien’s later period brought record potash volumes and higher quarterly revenue of US$10,609m in Q2 2026 versus US$10,198m a year earlier, which lined up with the optimistic case built on automation and capacity. Net income stayed roughly flat at about US$1.2b and net margin slipped from 12.0% to 11.4%, so the profitability upside in the bullish story remained only partly supported. Overall, the evidence cut both ways.

The key swing factor here was not potash volume itself but how much of that flowed through to earnings quality. For a different stock, you would test the same claim by matching any volume or capacity pitch against later shifts in net margin and absolute profit, not just headline sales.

What Nutrien’s Recent Run Already Prices In

Nutrien now trades at CA$99.97 after returning 22.7% over the past year, and the selected bullish Narrative still places its Fair Value above that quote rather than below it.

This view leans on automation, production flexibility and higher margin products, so any buyer today has to ask whether potash automation really can support structurally stronger profitability for years.

"Rapid automation and unmatched production flexibility position Nutrien for industry-leading margins, enhanced by its ability to quickly scale and dominate a tightening global market. Shifting toward sustainable, premium products and leveraging integrated ag services strengthens Nutrien's pricing power, recurring revenue, and resilience amid industry consolidation and supply chain turmoil."

One Narrative has put a figure on that disagreement. → See the Narrative with its higher Fair Value, assumptions and all

Find Your Own Contrarian Opportunity

What if your next investment idea came before the headlines? Go straight to the companies whose prices and our estimates still disagree. Three places to start, with the names waiting behind the link.

• Company 1 - 29% below our estimate - supplies complex networking and AI hardware as hyperscalers upgrade infrastructure.
• Company 2 - 40% below our estimate - feeds higher grade ore through existing mills to lift volumes and efficiency.
• Company 3 - 31% below our estimate - pushes a single high grade mine harder using plant tweaks and throughput changes.

Those are three of them. See every one of the 7 solid balance sheet companies →

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com